Felicitas Rohrer against Bayer by the anti-baby pill

In the year-long legal dispute over a possible health risk of the anti-baby pill "Yasminelle" has called a court, the counterparty to an agreement. The case w

Felicitas Rohrer against Bayer by the anti-baby pill

In the year-long legal dispute over a possible health risk of the anti-baby pill "Yasminelle" has called a court, the counterparty to an agreement. The case was complex and difficult, said the presiding judge, Claudia Jarsumbek on Thursday at the district court of Waldshut-Tiengen in Baden-Württemberg. A comparison of in court or out of court settlement would be the best solution. The time was up to 20. December. Otherwise, a process, of the mountains to both sides a high level of risk and could take years to complete the threat. It is a matter of complicated legal, medical, and liability questions. This could only be answered clearly.

In this case, the 34-year-old Felicitas Rohrer. She complains in the since June 2011, the ongoing civil legal proceedings against the chemical and Pharmaceutical company Bayer, based in Leverkusen, Germany. This distributes the pill.

risks of the contraceptive pill woman asks for pain money blood clot in the leg you should be over the thrombosis to know Of Ilona Kriesl

Rohrer, the prevention of power with its active ingredient, drospirenone for health problems and a high risk of thrombosis to be responsible. After taking it, you have, in June 2009, a bilateral pulmonary embolism and Circulatory collapse with a heart suffered downtime and had almost died. Only through a multi-hour surgery, she was saved by the Court, according to.

Still suffer today you will suffer the consequences, said the case of Offenburg within Ortenaukreis living woman on Thursday. It calls for Bayer's damages for Pain Betpas and suffering in the amount of at least EUR 200,000.

The pharmaceutical company believes that the claims asserted in the action are unfounded, said the lawyer of the company, Henning Moelle. There is no evidence that the anti-baby pill for the health problems of the applicant responsible. Scientific data confirms that of the pill and the active ingredient in the correct revenue is not at risk of going out in the suit.

For an agreement or an out-of-court settlement, there is currently no basis for it, said Moelle. The applicant Felicitas Rohrer, and her lawyer, Martin Jensch said, however, you could imagine an agreement.

opinion brings no clarity anti baby pill How dangerous are the newer pills?

A medical expert had not been able to clarify on Thursday, the cause of the health problems clearly. The life-threatening disease, the woman is likely due to the previous use of the pill, said the medic. Other causes are very unlikely. You could, however, be excluded without a doubt.

According to the report, many questions remained unanswered, said the judge. There is a lot of probabilities and uncertainties. You are therefore advise to the agreement. The process will continue to be worked on fundamental questions of time - and labor-intensive. This constitutes, for the applicant, a burden.

The pills the product group shall be taken after presentation of Bayer millions of times every day, in more than 100 countries. Already in five processes in Germany, where the disputed substance was gone, had Bayer won, said the company.

In the United States had complained to the company several Thousand women against Bayer. Until October 2016, the group closed with approximately 10,600 women comparisons over a total of about 2.1 billion US dollars, without, however, legally recognize effective responsibility. Additional lawsuits and claims of women were still being examined, it said.

In the case that is negotiated at the district court of Waldshut-Tiengen, it had given in December 2015, the first and up to this Thursday only hearing. Previously had replaced the Parties in writing. The court instructed after the hearing at the time, the medical experts who explained to well before the civil chamber of the court a total of three opinions.

Jürgen Ruf / DPA
Date Of Update: 27 October 2018, 19:02
NEXT NEWS